Jennifer Soung, MD: Let’s take a look at roflumilast and its itch response. I like to tell patients that they’re starting to see a response, or knowing that the topical is working since they can notice an itch relief as early as week 2. When we look at the data, you’re looking at approximately 67% of patients having at least a 4-point improvement in their itch score at week 8. That’s meaningful when you have plaque in a sensitive area and it’s really bothersome. Imagine plaque in the fold areas underneath the breast or in the genital area where you need that symptom relief.

LindaStein Gold, MD: I agree, especially due to the fact that it kicks in and we do see separation early on. As you mentioned by the end of week 8, about two-thirds of those patients have that 4-grade improvement in the itch, which is a very meaningful improvement. We always ask our atopic patients, “How’s your itching?” We must make sure that we ask our patients with psoriasis as well.

Jennifer Soung, MD: We’ve talked a lot about sensitive areas like the face, underarms and genitals. Does this topical work for those really thick areas like the knees, or elbows?

Transcript edited for clarity

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!